Want to see DVA full AI Analyst Report?
Adjusted Operating Profit by Segment
Reflects the profitability of each segment after adjustments, offering a clearer picture of core earnings and financial health.Dialysis remains the real profit engine and has staged a clear recovery that underpins management’s guidance raise, while Ancillary Services has moved from a recurring drag to episodic profitability—these swings look driven more by timing, IKC program dynamics and mix than by steady margin improvement. Corporate costs have ticked up due to strategic technology and AI investments, creating near‑term margin pressure even as productivity gains materialize. Key risks: can ancillary profits sustain and can rising G&A be absorbed before free‑cash conversion and interest costs limit upside?
Date | Dialysis | Ancillary Services | Corporate |
|---|---|---|---|
Jun 30, 2026 | $538.00M | $57.00M | -$16.00M |
Mar 31, 2026 | $506.00M | $6.00M | -$30.00M |
Dec 31, 2025 | $556.00M | $62.00M | -$32.00M |
Sep 30, 2025 | $542.00M | $1.00M | -$26.00M |
Jun 30, 2025 | $536.00M | $57.00M | -$42.00M |
Mar 31, 2025 | $476.00M | -$3.00M | -$34.00M |
Dec 31, 2024 | $482.00M | $25.00M | -$29.00M |
Sep 30, 2024 | $549.00M | $14.00M | -$29.00M |
Jun 30, 2024 | $550.00M | -$19.00M | -$25.00M |
Mar 31, 2024 | $505.00M | -$12.00M | -$30.00M |